Form 8-K Medicus Pharma Ltd. For: Dec 29
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- CAE agrees to sell Flightscape unit to SITA for $500 million
Medicus Pharma establishes $15.3 million at-the-market equity program
December 30, 2025 9:29 AM ESTMedicus Pharma Ltd. (NASDAQ: MDCX) entered into an equity distribution agreement on December 29, 2025, with Maxim Group LLC and Yorkville Securities LLC to establish an at-the-market equity program worth up to $15,349,674.
Under the agreement, the company may sell common shares from... More



